Diving Into Rare Childhood Leukemias

Since first described over thirty years ago, acute leukemia defying conventional lineage assignment as ALL or AML have posed a therapeutic conundrum. With only limited insight available into the underlying biology for “bi-phenotypic” or “mixed phenotype a